BMS - International Pharmaceutical Industry

HOME
CURRENT
FEATURES
EDITORIAL
ARCHIVES
ARCHIVED
ISSUES
EVENTS
COMPANY
PROFILES
A-D

E-M

N-S

T-Z
SPONSORED
ARTICLES
NEWS
EBOOKS

SCHOTT Pharma
PODCAST
Generic selectors

Exact matches only

Search in title

Search in content

Post Type Selectors

Current Edition

News

Opdivo plus chemo improves event-free survival in NSCLC patients

Bristol Myers Squibb (BMS) has announced that its PD-1 inhibitor Opdivo (nivolumab) plus chemotherapy improved event-free survival in a Phase III trial in patients w...

9 November 2021 News BMS | Bristol Myers Squibb

Continue Reading →

News

B Medical Systems – Production Area Extension

The new factory extension of B Medical Systems, a global leader in the vaccine cold chain, was inaugurated by the Honourable Luxembourg Minister of Economy, Mr Franz...